Capital Advisors Ltd’s CONMED CNMD Stock Holding History

Capital Advisors Ltd’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	–	–	1371
2025 Q1	$0	Buy	+1	New	+$64	﹤0.01%	1375

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital Advisors Ltd's CNMD Position: Q2 2025 in Review

Capital Advisors Ltd sold out of CONMED (CNMD) in Q2 2025, closing a stake of 1 share.

Capital Advisors Ltd first reported a position in CNMD in Q1 2025 and held it in 1 quarter. The position peaked at $0 in Q1 2025. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

Capital Advisors Ltd reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
Capital Advisors Ltd sold 1 CONMED share in Q2 2025.
Capital Advisors Ltd first reported a position in CONMED in Q1 2025 and held it in 1 quarter.
Capital Advisors Ltd's CONMED position peaked at $0 in Q1 2025.
276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Capital Advisors Ltd's 13F filing for Q2 2025, filed 24 Jul 2025.